175 related articles for article (PubMed ID: 24679922)
41. Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone.
Leggio GM; Camillieri G; Platania CB; Castorina A; Marrazzo G; Torrisi SA; Nona CN; D'Agata V; Nobrega J; Stark H; Bucolo C; Le Foll B; Drago F; Salomone S
Neuropsychopharmacology; 2014 Jul; 39(8):2017-28. PubMed ID: 24584330
[TBL] [Abstract][Full Text] [Related]
42. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.
Tziortzi AC; Searle GE; Tzimopoulou S; Salinas C; Beaver JD; Jenkinson M; Laruelle M; Rabiner EA; Gunn RN
Neuroimage; 2011 Jan; 54(1):264-77. PubMed ID: 20600980
[TBL] [Abstract][Full Text] [Related]
43. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.
Newman AH; Blaylock BL; Nader MA; Bergman J; Sibley DR; Skolnick P
Biochem Pharmacol; 2012 Oct; 84(7):882-90. PubMed ID: 22781742
[TBL] [Abstract][Full Text] [Related]
44. Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus.
Seeman P; Wilson A; Gmeiner P; Kapur S
Synapse; 2006 Sep; 60(3):205-11. PubMed ID: 16739118
[TBL] [Abstract][Full Text] [Related]
45. Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.
Simpson EH; Winiger V; Biezonski DK; Haq I; Kandel ER; Kellendonk C
Biol Psychiatry; 2014 Nov; 76(10):823-31. PubMed ID: 24387821
[TBL] [Abstract][Full Text] [Related]
46. Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers.
Jangard S; Jayaram-Lindström N; Isacsson NH; Matheson GJ; Plavén-Sigray P; Franck J; Borg J; Farde L; Cervenka S
Addiction; 2023 Jun; 118(6):1053-1061. PubMed ID: 36710462
[TBL] [Abstract][Full Text] [Related]
47. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.
Payer DE; Guttman M; Kish SJ; Tong J; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
Neurology; 2016 Jan; 86(3):224-30. PubMed ID: 26718579
[TBL] [Abstract][Full Text] [Related]
48. Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.
Sóvágó J; Farde L; Halldin C; Langer O; Laszlovszky I; Kiss B; Gulyás B
Neurochem Int; 2004 Oct; 45(5):609-17. PubMed ID: 15234102
[TBL] [Abstract][Full Text] [Related]
49. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
Kodaka F; Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Okumura M; Otsuka T; Nakayama K; Halldin C; Farde L; Suhara T
Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881
[TBL] [Abstract][Full Text] [Related]
50. Effect of scan-time shortening on the
Matsunaga K; Tonomura M; Abe K; Shimosegawa E
Ann Nucl Med; 2023 Apr; 37(4):227-237. PubMed ID: 36656501
[TBL] [Abstract][Full Text] [Related]
51. In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography.
te Beek ET; de Boer P; Moerland M; Schmidt ME; Hoetjes NJ; Windhorst AD; van Berckel BN; Cohen AF; van Gerven JM; Lammertsma AA
J Psychopharmacol; 2012 Aug; 26(8):1128-35. PubMed ID: 22290934
[TBL] [Abstract][Full Text] [Related]
52. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
[TBL] [Abstract][Full Text] [Related]
53. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
54. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.
Karimi M; Moerlein SM; Videen TO; Su Y; Flores HP; Perlmutter JS
Mov Disord; 2013 Dec; 28(14):2002-6. PubMed ID: 24151192
[TBL] [Abstract][Full Text] [Related]
55. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
[TBL] [Abstract][Full Text] [Related]
56. PET imaging predicts future body weight and cocaine preference.
Michaelides M; Thanos PK; Kim R; Cho J; Ananth M; Wang GJ; Volkow ND
Neuroimage; 2012 Jan; 59(2):1508-13. PubMed ID: 21889993
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
[TBL] [Abstract][Full Text] [Related]
58. Association between striatal dopamine D2/D3 receptors and brain activation during visual attention: effects of sleep deprivation.
Tomasi D; Wang GJ; Volkow ND
Transl Psychiatry; 2016 May; 6(5):e828. PubMed ID: 27244237
[TBL] [Abstract][Full Text] [Related]
59. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
60. A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.
Matuskey D; Gaiser EC; Gallezot JD; Angarita GA; Pittman B; Nabulsi N; Ropchan J; MaCleod P; Cosgrove KP; Ding YS; Potenza MN; Carson RE; Malison RT
Drug Alcohol Depend; 2015 Sep; 154():167-73. PubMed ID: 26164205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
